Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.408 EUR | +0.87% | +3.29% | -11.30% |
May. 07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 0.4220 | 0.6000 | 0.5470 |
Spread/Res. | -3.32% | -32.00% | -25.41% |
Spread/Supp. | +4.35% | +20.35% | +5.70% |
Support | 0.3910 | 0.3390 | 0.3860 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- SIGHT Stock
- Charts GenSight Biologics S.A.